Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY:ABT)

134.44 +0.33 (+0.25%)
Official Closing Price Updated: 5:00 PM EDT, Jul 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2 3 4 5 6 7 8 9
...
45 46 Next >
Jensen Huang, Magic Johnson, Patrick Dempsey, Linda Yaccarino And More Bigwigs Headline Milken Global Conference 2025: What You Need To Know
The Milken Institute's 28th annual Global Conference, featuring prominent figures like Jensen Huang, Magic Johnson, and Linda Yaccarino, is focusing on key global issues such as AI, healthcare, and... 
Via Benzinga
Topics Artificial Intelligence
Here Are All the Dividend Kings Beating the S&P 500 in 2025 -- and the 2 That Are the Best Stocks to Buy Now
Via The Motley Fool
Topics Government Stocks World Trade
2 Stocks, 2 Decades, $200. Is This the Long-Term Dividend Play for Your Portfolio?
Via The Motley Fool
If A Recession Hits, Will Medical Stocks Be A Safe Haven For Investors — Again?
Medical stocks are usually considered defensive. But have they been too hammered by regulatory changes to hold up this year? 
Via Investor's Business Daily
Topics Animal Testing Economy Government
Abbott Laboratories (NYSE:ABT) Shows Strong Technical Breakout Potential
Abbott Laboratories (NYSE:ABT) Shows Strong Technical Breakout Potential 
Via Chartmill
A Look Into Abbott Laboratories Inc's Price Over Earnings
Via Benzinga
3 Dividend Stocks to Buy and Hold for the Next Decade
Via The Motley Fool
If You Wanted To Buy AbbVie and Didn’t, There’s Still Time To Buy
AbbVie is well-positioned for industry-leading growth, as Skyrizi and Rinvoq sales outperform, driving system-wide growth alongside a diversified portfolio. 
Via MarketBeat
What To Expect From Penumbra’s (PEN) Q1 Earnings
Medical device company Penumbra (NYSE:PEN) will be reporting results tomorrow after the bell. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence
Earnings To Watch: ResMed (RMD) Reports Q1 Results Tomorrow
Medical device company ResMed (NYSE:RMD) will be announcing earnings results tomorrow after market close. Here’s what to look for. 
Via StockStory
Topics Artificial Intelligence
What To Expect From Boston Scientific’s (BSX) Q1 Earnings
Medical device company Boston Scientific (NYSE:BSX) will be reporting results tomorrow before market open. Here’s what to look for. 
Via StockStory
Topics Economy
Earnings To Watch: Intuitive Surgical (ISRG) Reports Q1 Results Tomorrow
Medical technology company Intuitive Surgical (NASDAQ:ISRG) will be reporting results tomorrow after market close. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Dividend Stock Analysis: Abbott Laboratories
The company is focused on nutritionals, diagnostics, generic drugs, and medical devices. 
Via Talk Markets
Topics Stocks / Equities
These Analysts Boost Their Forecasts On Abbott Laboratories After Better-Than-Expected Earnings
Via Benzinga
Demystifying Abbott Laboratories: Insights From 11 Analyst Reviews
Via Benzinga
5 Dividend Aristocrats® So Good You'll Never Want to Sell
Turn $180 into $7M? These 5 Dividend Aristocrats show how it's possible. 
Via The Motley Fool
Tariff-Resistant Abbott Laboratories on Track for New Highs
Abbott Laboratories stock price is on track to hit a new high in 2025 and could do it before the end of the first half. Dividends and buybacks help. 
Via MarketBeat
Topics World Trade
US Stocks Likely To Open Higher Ahead Of Festive Weekend: 'Current Equity Levels Offer An Attractive Entry Opportunity'
U.S. stock futures rose on Thursday ahead of the long weekend, with Good Friday falling on April 18 and Easter Sunday on April 20. 
Via Benzinga
Nasdaq Dips 3% Amid Plunge In Nvidia, AMD: Greed Index Remains In 'Extreme Fear' Zone
Via Benzinga
Healthcare Sector Update: MEDtech And Diagnostics
Amidst the tariff chaos, we may get clues from one of the most defensive sectors of the market-healthcare stocks. 
Via Talk Markets
Topics ETFs Stocks / Equities World Trade
Stay informed with the top movers within the S&P500 index on Wednesday.
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Wednesday. 
Via Chartmill
Stocks Sink As Powell Dismisses 'Fed Put' Safety Net, Gold Extends Massive Lead Over Nasdaq
Powell says tariffs could lead to higher inflation and slower growth, but Fed won't intervene in market losses. Stocks tumble, gold prices rise. 
Via Benzinga
Topics Economy World Trade
Discover which S&P500 stocks are making waves on Wednesday.
Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top S&P500 gainers and losers in today's session. 
Via Chartmill
Nvidia Drags Wall Street Down, Gold Defies Gravity Ahead Of Powell Remarks: What's Driving Markets Wednesday?
U.S. major indices traded lower at midday Wednesday, pressured by sharp declines in tech and semiconductor stocks after Washington tightened chip export restrictions to China. 
Via Benzinga
Abbott Laboratories (ABT) Shares Skyrocket, What You Need To Know
Shares of healthcare product and device company Abbott Laboratories (NYSE:ABT) jumped 5.4% in the morning session after the company reported decent first-quarter 2025 results with revenue in line,... 
Via StockStory
Nasdaq Down Over 2%; Abbott Laboratories Posts Upbeat Earnings
Via Benzinga
Abbott Stock Rises On Strong Q1 Earnings: Retail’s In Wait-And-Watch Mode
Abbott reaffirmed its full-year 2025 financial guidance and expects full-year 2025 adjusted diluted earnings per share of $5.05 to $5.25. 
Via Stocktwits
Topics Government
Abbott Labs Clocks Q1 Profit Beat, CEO Says Diversification And Execution Enable Navigation During Uncertainty
Abbott reaffirmed its 2025 EPS guidance supported by strong Diabetes and Nutrition growth. 
Via Benzinga
Abbott Laboratories Dips As Sales Come In Light Despite Profit Beat
Abbott stock slipped early Wednesday after the health giant reported light first-quarter sales, though profit beat views. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 7 8 9
...
45 46 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.